166 related articles for article (PubMed ID: 17763181)
1. Adiponectin, obesity and atherosclerosis.
Behre CJ
Scand J Clin Lab Invest; 2007; 67(5):449-58. PubMed ID: 17763181
[TBL] [Abstract][Full Text] [Related]
2. The role of adiponectin in obesity, diabetes, and cardiovascular disease.
Kawano J; Arora R
J Cardiometab Syndr; 2009; 4(1):44-9. PubMed ID: 19245516
[TBL] [Abstract][Full Text] [Related]
3. [Adiponectin and atherosclerosis].
Haluzíková D; Roubícek T; Haluzík M
Vnitr Lek; 2007 Apr; 53(4):359-63. PubMed ID: 17578166
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin and its potential in the treatment of obesity, diabetes and insulin resistance.
Haluzik M
Curr Opin Investig Drugs; 2005 Oct; 6(10):988-93. PubMed ID: 16259219
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin and cardiovascular disease: response to therapeutic interventions.
Han SH; Quon MJ; Kim JA; Koh KK
J Am Coll Cardiol; 2007 Feb; 49(5):531-8. PubMed ID: 17276175
[TBL] [Abstract][Full Text] [Related]
6. [Adiponectin and its role in the pathogenesis of obesity, diabetes mellitus and insulin resistance].
Owecki M; Sowiński J
Pol Merkur Lekarski; 2006 Mar; 20(117):355-7. PubMed ID: 16780274
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease.
Lara-Castro C; Fu Y; Chung BH; Garvey WT
Curr Opin Lipidol; 2007 Jun; 18(3):263-70. PubMed ID: 17495599
[TBL] [Abstract][Full Text] [Related]
8. [Research advancement of adipocytokine adiponectin].
Xiao FY; Lu FE
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):309-13. PubMed ID: 14992011
[TBL] [Abstract][Full Text] [Related]
9. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
Tilg H; Moschen AR
Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
[TBL] [Abstract][Full Text] [Related]
10. Metabolic actions of adipocyte hormones: focus on adiponectin.
Ahima RS
Obesity (Silver Spring); 2006 Feb; 14 Suppl 1():9S-15S. PubMed ID: 16642957
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin, obesity, and cardiovascular disease.
Fasshauer M; Paschke R; Stumvoll M
Biochimie; 2004 Nov; 86(11):779-84. PubMed ID: 15589686
[TBL] [Abstract][Full Text] [Related]
12. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
Kieć-Klimczak M; Malczewska-Malec M; Huszno B
Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
[TBL] [Abstract][Full Text] [Related]
13. Infection-induced inflammatory response of adipocytes in vitro.
Bouwman JJ; Visseren FL; Bouter KP; Diepersloot RJ
Int J Obes (Lond); 2008 Jun; 32(6):892-901. PubMed ID: 18347604
[TBL] [Abstract][Full Text] [Related]
14. Human serum levels of fetal antigen 1 (FA1/Dlk1) increase with obesity, are negatively associated with insulin sensitivity and modulate inflammation in vitro.
Chacón MR; Miranda M; Jensen CH; Fernández-Real JM; Vilarrasa N; Gutiérrez C; Näf S; Gomez JM; Vendrell J
Int J Obes (Lond); 2008 Jul; 32(7):1122-9. PubMed ID: 18392037
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular actions of adiponectin: pathophysiologic implications.
Maia-Fernandes T; Roncon-Albuquerque R; Leite-Moreira AF
Rev Port Cardiol; 2008 Nov; 27(11):1431-49. PubMed ID: 19227810
[TBL] [Abstract][Full Text] [Related]
16. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
17. Obesity and inflammation: lessons from bariatric surgery.
Compher C; Badellino KO
JPEN J Parenter Enteral Nutr; 2008; 32(6):645-7. PubMed ID: 18974245
[TBL] [Abstract][Full Text] [Related]
18. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
19. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
20. Adipokines: the missing link between insulin resistance and obesity.
Antuna-Puente B; Feve B; Fellahi S; Bastard JP
Diabetes Metab; 2008 Feb; 34(1):2-11. PubMed ID: 18093861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
